CNS vs PNS, Neuron Signalling & Synaptic Transmission
A complete guide to neural architecture and communication — from the structural organisation of the central and peripheral nervous systems through neuron anatomy, membrane biophysics, action potential generation and propagation, myelination, chemical synaptic transmission, neurotransmitter pharmacology, synaptic integration, the neuromuscular junction, synaptic plasticity, autonomic function, and the clinical consequences of signalling failure.
Every thought you form, every movement you make, every sensation you experience — the beating of your heart, the digestion of a meal, the reflex that pulls your hand from a hot surface before your brain even registers the pain — all of it is generated and coordinated by roughly 86 billion neurons organised into the most complex biological information-processing system known. The nervous system does not merely transmit signals passively, like electrical wires. It actively filters, amplifies, integrates, modulates, and stores information through mechanisms that operate simultaneously at the molecular level (ion channel gating in microseconds), the cellular level (action potential generation and propagation in milliseconds), the synaptic level (neurotransmitter release and receptor activation), and the circuit level (networks that produce perception, cognition, and behaviour). Understanding how this system is organised and how it communicates is foundational to all of biology, medicine, and psychology.
The Nervous System — Divisions, Functions, and Structural Logic
The nervous system is divided anatomically and functionally into two major subdivisions whose properties reflect their different roles: the central nervous system (CNS) — the command and processing centre — and the peripheral nervous system (PNS) — the communication network that links the CNS to every tissue in the body. This two-division organisation is not arbitrary; it reflects fundamental differences in cellular architecture, regenerative capacity, immune privilege, and the nature of the computations each division performs.
The functional logic of the nervous system can be understood through three core operations that all neural circuits perform: sensory input — detecting changes in the internal and external environment through specialised receptor cells and transmitting the encoded information centrally; integration — processing, comparing, filtering, and weighing incoming signals against stored information and current behavioural goals to determine appropriate outputs; and motor output — sending commands to effector organs (muscles, glands) to produce physiologically appropriate responses. These three operations are localised differently in the CNS and PNS, with the integration occurring centrally and the input/output occurring through peripheral nerves.
Central Nervous System — Brain Architecture and Spinal Cord Organisation
The CNS consists of two anatomically distinct components — the brain and the spinal cord — united by their shared location within the bony cranium and vertebral column, their common envelopment by the meninges (dura mater, arachnoid mater, pia mater) and cerebrospinal fluid, and their shared reliance on a continuous blood supply protected by the blood-brain barrier. According to the NCBI StatPearls reference on CNS neuroanatomy, the central nervous system represents the anatomical and functional axis around which all neural processing is organised, with every peripheral nerve ultimately communicating centrally through spinal or cranial nerve entry points.
Cerebral Cortex — the Seat of Higher Neural Processing
The cerebral cortex is the deeply folded outer layer of the cerebrum, consisting of approximately 2–4 mm of grey matter containing neuronal cell bodies organised into six horizontal layers (I–VI) with distinct input and output connectivity. Its highly convoluted surface (gyri and sulci) dramatically increases total surface area to approximately 2,500 cm² — far more than the available skull volume would allow without folding. The cortex is divided into four lobes per hemisphere, each with distinct functional specialisations that emerge from the specific circuits they contain rather than from any intrinsic property of cortical tissue itself.
The frontal lobe contains the primary motor cortex (precentral gyrus — executes voluntary movements organised somatotopically as the motor homunculus), premotor and supplementary motor areas (planning and sequencing movements), Broca’s area (speech production, dominant hemisphere), and the prefrontal cortex (executive function, working memory, decision-making, social cognition). The parietal lobe contains the primary somatosensory cortex (postcentral gyrus — processes touch, pressure, proprioception, and temperature, also somatotopically organised as the sensory homunculus), and higher-order areas for spatial processing, body awareness, and sensory integration. The temporal lobe contains primary auditory cortex (Heschl’s gyrus), Wernicke’s area (language comprehension, dominant hemisphere), and portions of the visual object-recognition pathway (inferior temporal cortex — the “what” pathway), as well as the hippocampus medially — critical for declarative memory consolidation. The occipital lobe is dominated by primary visual cortex (V1, around the calcarine sulcus) and higher visual processing areas (V2–V5), including the dorsal “where/how” pathway and ventral “what” pathway for object recognition.
Beneath the cortex, the white matter consists of myelinated axon tracts carrying information between cortical areas (association fibres), between hemispheres (commissural fibres — most importantly the corpus callosum, connecting the two hemispheres through approximately 200–300 million axons), and between cortex and subcortical structures or spinal cord (projection fibres — including the corticospinal tract for voluntary motor control).
Subcortical Structures — Thalamus, Hypothalamus, Basal Ganglia, and Limbic System
The thalamus is a paired diencephalic structure that functions as the principal relay and gating station for information reaching the cortex. Nearly all sensory information (except olfaction) is relayed through specific thalamic nuclei before reaching its cortical destination: the lateral geniculate nucleus for visual information, the medial geniculate nucleus for auditory information, and the ventral posterior complex for somatosensory information. The thalamus does not passively relay signals — it actively gates sensory transmission depending on arousal state (dramatically reducing transmission during deep sleep, explaining the reduced sensory awareness of sleep) and participates in attention by modulating which inputs receive cortical access.
The hypothalamus, despite weighing only approximately 4 grams, is the master regulator of homeostasis and neuroendocrine function. It controls body temperature, hunger, thirst, circadian rhythm, sleep-wake cycles, and reproductive behaviour, and drives the autonomic nervous system and the pituitary gland through direct neural connections and hormone release. The hypothalamus-pituitary-adrenal (HPA) axis, activated by hypothalamic CRH release, orchestrates the entire stress hormone response from cortisol release through gluconeogenesis and immune modulation. The basal ganglia (caudate nucleus, putamen, globus pallidus, substantia nigra, subthalamic nucleus) form a circuit for motor program selection and movement initiation — they do not execute movements directly but modulate the thalamocortical circuits that do, through parallel direct (movement-facilitating) and indirect (movement-suppressing) pathways. Loss of dopaminergic neurons in the substantia nigra pars compacta — the hallmark of Parkinson’s disease — shifts basal ganglia output toward excessive inhibition, producing the characteristic bradykinesia, rigidity, and tremor of this condition.
The cerebellum, which contains approximately 80% of all neurons in the brain despite representing only 10% of brain volume (reflecting its dense packing of granule cells), is the centre for motor coordination, precision, and learning. It receives copies of motor commands from the cortex and sensory feedback from the periphery, and uses the discrepancy between intended and actual movement to generate corrective signals through its principal output cells, the Purkinje neurons. Cerebellar damage produces ataxia (incoordination), intention tremor, and dysmetria (misjudging distances in directed movements) — none of which involve weakness, because the cerebellum modulates rather than drives movement.
Spinal Cord — Organisation of Ascending and Descending Pathways
The spinal cord is a cylindrical neural structure approximately 45 cm long in adults, extending from the foramen magnum of the skull to the L1–L2 vertebral level, where it tapers into the conus medullaris and the cauda equina of individual nerve roots. In cross-section, the spinal cord is organised into central grey matter (butterfly-shaped, containing neuronal cell bodies) and surrounding white matter (myelinated axon tracts). The grey matter is divided into dorsal horns (receiving incoming sensory signals), ventral horns (containing motor neurons whose axons form the motor roots of spinal nerves and innervate skeletal muscles), and lateral horns (present in thoracic and upper lumbar segments, containing preganglionic sympathetic neurons). The white matter contains ascending sensory tracts (dorsal columns carrying fine touch and proprioception; spinothalamic tract carrying pain and temperature) and descending motor tracts (corticospinal tract for voluntary movement; reticulospinal, vestibulospinal, and rubrospinal tracts for posture and automatic movement).
Peripheral Nervous System — Somatic, Autonomic, and Enteric Divisions
The peripheral nervous system extends from the CNS to every target tissue in the body through a network of 12 pairs of cranial nerves (emerging directly from the brain) and 31 pairs of spinal nerves (8 cervical, 12 thoracic, 5 lumbar, 5 sacral, 1 coccygeal). Each spinal nerve is formed by the union of a dorsal root (carrying sensory afferents, with cell bodies in the dorsal root ganglion) and a ventral root (carrying motor efferents, with cell bodies in the ventral horn). The PNS divides functionally into two major subdivisions whose differences in anatomy, neurotransmitter chemistry, and target organs reflect their distinct physiological roles.
Voluntary Sensorimotor Control
The somatic division handles conscious, voluntary interactions with the external environment. It contains afferent (sensory) fibres transmitting information from skin, muscle, and joints — mechanoreception (touch, pressure, vibration), thermoreception (temperature), nociception (pain), and proprioception (body position and movement). Its efferent limb consists of lower motor neurons whose axons travel directly from the ventral horn of the spinal cord (or motor nuclei of cranial nerves) to skeletal muscle fibres at the neuromuscular junction, forming a monosynaptic connection. Somatic motor commands are under voluntary cortical control and generate conscious skeletal movement. The somatic motor system obeys the final common pathway principle: all descending motor influences converge on the same lower motor neurons, making them the last point of integration before the muscle.
Involuntary Visceral Regulation
The autonomic division regulates involuntary visceral functions — heart rate, blood pressure, breathing, digestion, bladder emptying, glandular secretion, pupil diameter, body temperature. Unlike somatic motor pathways (one neuron from spinal cord to muscle), autonomic pathways use a two-neuron chain: a preganglionic neuron in the CNS synapses in a peripheral ganglion onto a postganglionic neuron that innervates the target organ. This arrangement allows the autonomic nervous system to integrate CNS commands with local tissue conditions. The two divisions — sympathetic (fight-or-flight, thoracolumbar outflow) and parasympathetic (rest-and-digest, craniosacral outflow) — typically exert opposing effects on the same target organs, enabling fine-tuned control of visceral function by shifting the balance of dual innervation.
Thoracolumbar — Fight-or-Flight
Sympathetic preganglionic neurons originate in the lateral horn of T1–L2 spinal segments and synapse in the paravertebral sympathetic chain ganglia (or prevertebral ganglia for abdominal organs), using acetylcholine on nicotinic receptors. Postganglionic fibres innervate target organs using noradrenaline on α and β adrenoreceptors (except sweat glands, which use ACh). Sympathetic activation produces: increased heart rate and force, bronchodilation, reduced GI motility, vasoconstriction in gut/skin/non-essential tissues, vasodilation in skeletal muscle, glycogenolysis in liver, lipolysis in fat, and pupil dilation — coordinating the organism for rapid physical action or stress response. The adrenal medulla is a modified sympathetic ganglion that releases adrenaline and noradrenaline directly into the bloodstream as hormones, amplifying and prolonging the sympathetic response systemically.
Craniosacral — Rest-and-Digest
Parasympathetic preganglionic neurons arise from cranial nerve nuclei (III, VII, IX, X) in the brainstem and from sacral segments S2–S4, with long preganglionic fibres synapsing in ganglia located near or within target organs. Both preganglionic and postganglionic parasympathetic neurons use acetylcholine — preganglionic on nicotinic receptors in ganglia, postganglionic on muscarinic receptors (M1–M5) at target organs. Parasympathetic activation produces effects generally opposite to sympathetic: reduced heart rate (vagal brake), bronchoconstriction, increased GI motility and secretion, bladder contraction, pupil constriction, increased glandular secretion (salivary, lacrimal). The vagus nerve (cranial nerve X) mediates approximately 75% of all parasympathetic outflow, innervating the heart, lungs, and most abdominal organs — explaining why vagal tone manipulation (vagus nerve stimulation) has wide therapeutic applications.
The “Second Brain” of the Gut
The enteric nervous system (ENS) is an intrinsic neural network embedded in the wall of the gastrointestinal tract — from the oesophagus to the internal anal sphincter — containing approximately 100 to 500 million neurons in two interconnected ganglionated plexuses: the myenteric (Auerbach’s) plexus between muscle layers (controlling motility) and the submucosal (Meissner’s) plexus (controlling secretion and blood flow). The ENS uses over 30 neurotransmitters, including serotonin (95% of the body’s total 5-HT is in the gut, produced by enterochromaffin cells), acetylcholine, NO, VIP (vasoactive intestinal peptide), and substance P. It coordinates peristalsis, segmentation, and secretion autonomously without input from the CNS — surgically isolated gut segments continue peristalsis normally — though autonomic modulation fine-tunes ENS function through sympathetic and parasympathetic inputs.
Size, Myelin, and Conduction Velocity
Peripheral nerve fibres are classified by diameter and myelination into types that determine their conduction speed and function. Type A-alpha (Aα): 12–20 µm diameter, heavily myelinated, 70–120 m/s — proprioception, skeletal motor. A-beta (Aβ): 6–12 µm, myelinated, 30–70 m/s — touch, pressure, vibration. A-delta (Aδ): 1–5 µm, lightly myelinated, 5–30 m/s — sharp/fast pain, cold. B fibres: <3 µm, lightly myelinated, 3–15 m/s — autonomic preganglionic. C fibres: 0.2–1.5 µm, unmyelinated, 0.5–2 m/s — slow/burning pain, warm temperature, postganglionic autonomic. The bimodal pain response after injury — an immediate sharp "first pain" (Aδ) followed by a delayed burning "second pain" (C) — directly reflects the conduction velocity difference between these fibre types.
Neuron Anatomy — the Structural Basis of Signal Reception, Integration, and Transmission
The neuron is the fundamental cellular unit of neural signalling. While neurons vary enormously in size, shape, and function — compare the 1 mm Purkinje neuron dendrite tree of the cerebellum to the 1-metre motor axon reaching from the lumbar spinal cord to the foot — all neurons share a common structural organisation that directly reflects their functional role: receiving electrochemical signals at one end, integrating them in a central compartment, and transmitting an output signal along a single conducting process to the next cell in the circuit.
Dendrites — Signal Reception and Initial Processing
Dendrites are branching cytoplasmic extensions of the neuronal cell body that dramatically increase the surface area available to receive synaptic inputs. A single cortical pyramidal neuron may receive 10,000–30,000 synaptic inputs across its dendritic tree. Dendritic spines — small protrusions studding most excitatory synapses on cortical and hippocampal neurons — increase surface area further and compartmentalise Ca²⁺ signalling, enabling individual synapses to be strengthened or weakened independently (the structural basis of synaptic specificity in learning). Dendrites are not simply passive wires: they express voltage-gated channels (Na⁺, Ca²⁺, K⁺, and hyperpolarisation-activated HCN channels) that actively shape the way incoming synaptic potentials are processed, amplified, attenuated, and conducted toward the cell body. Active dendritic conductances can support dendritic spikes, enable coincidence detection, and implement complex nonlinear computations — dendrites are computational elements, not just antennae.
Soma (Cell Body) — Metabolic Centre and Signal Integrator
The soma, or perikaryon, contains the nucleus (housing the neuronal genome — the blueprint for all the proteins that define the neuron’s identity, connectivity, and physiology), the rough endoplasmic reticulum (Nissl substance — prominent in motor neurons, reflecting their high protein synthesis demands), the Golgi apparatus, mitochondria, and the cytoskeleton. The soma is the metabolic engine of the neuron: it synthesises virtually all proteins, including ion channels, receptors, synaptic vesicle proteins, and structural components, for distribution throughout the extensive axon and dendritic tree by axonal transport (fast anterograde at ~400 mm/day via kinesin; fast retrograde at ~200–300 mm/day via dynein; slow anterograde at 1–10 mm/day for cytoskeletal proteins). The soma also receives synaptic inputs directly on its surface, which can be strongly inhibitory — axosomatic inhibitory synapses from interneurons (such as chandelier cells targeting the axon initial segment, and basket cells targeting the soma) powerfully control neuronal firing.
Axon Hillock and Initial Segment — the Decision Zone
The axon hillock is the cone-shaped region of the soma where the axon originates. It transitions into the axon initial segment (AIS) — a structurally specialised 20–60 µm stretch of unmyelinated axon whose defining feature is an exceptionally high density of voltage-gated Na⁺ channels (Nav1.6 and Nav1.2 subtypes), approximately 50–100 times higher than in the soma or dendrites. This concentration of Na⁺ channels makes the AIS the most excitable region of the neuron — the site with the lowest threshold for action potential generation. All the graded electrical signals arriving from dendrites and soma (EPSPs and IPSPs, possibly numbering thousands per second) converge as they reach the AIS, where their algebraic sum either reaches threshold and triggers an action potential or fails to do so. The AIS is the neuron’s decision zone — the site where analogue dendritic computation is converted into a digital all-or-nothing output. The scaffold protein ankyrin-G anchors Na⁺ channels and other AIS-specific components; disruption of AIS organisation by injury or disease directly alters neuronal excitability.
Axon — Long-Distance Signal Propagation
The axon is the neuron’s single, specialised output process — a thin cylindrical extension (1–20 µm diameter in the PNS, <1 µm for many CNS interneurons) that propagates action potentials from the AIS to the axon terminals, sometimes over distances of a metre or more in peripheral motor and sensory neurons. Unlike dendrites, axons maintain a relatively uniform diameter, lack ribosomes, and propagate action potentials with faithful, undecremented amplitude thanks to the active regeneration of the signal at each node (in myelinated axons) or along the full length (in unmyelinated fibres). Axons may branch (collaterals), allowing a single neuron to contact many different target neurons simultaneously — a single motor neuron's axon may branch to innervate hundreds of individual muscle fibres (the motor unit), and single cortical pyramidal neuron axons send collaterals to multiple cortical areas, subcortical structures, and spinal cord simultaneously.
Axon Terminals and Synaptic Boutons — the Output Interface
Axon terminals (synaptic boutons or end bulbs) are the enlarged, specialised endings at the tips of axonal branches where chemical synaptic transmission occurs. They are packed with synaptic vesicles (40–50 nm diameter spheres each containing several thousand molecules of neurotransmitter), mitochondria (providing ATP for vesicle recycling, ion pump activity, and neurotransmitter synthesis), and the molecular machinery for vesicle docking and fusion. Voltage-gated Ca²⁺ channels (particularly P/Q-type Cav2.1 and N-type Cav2.2) are concentrated in the active zone — the precise region of the presynaptic membrane facing the postsynaptic density — ensuring that Ca²⁺ influx occurs exactly where vesicle fusion is needed. A single neuron may have thousands of individual boutons distributed across its axonal arbour, each forming an independent synaptic contact. En passant synapses (where axons form synaptic contacts along their length without terminal swellings) are particularly common in autonomic and monoamine pathways.
Glial Cells — Neural Support, Myelination, and Active Circuit Participation
For most of the twentieth century, glial cells were considered passive structural supports — the scaffolding that held neurons in place. That view has been thoroughly overturned. Glia actively maintain the ionic and chemical environment neurons require to function, form the myelin sheaths that enable fast conduction, regulate synaptic transmission by controlling neurotransmitter availability, participate in immune surveillance, and shape neural circuit development and plasticity. The major glial cell types each perform distinct and essential functions that no neuron can replace.
Astrocytes — the Homeostatic Regulators
The most numerous CNS glial cell type (approximately equal in number to neurons in most regions), astrocytes perform indispensable homeostatic functions. Perivascular astrocyte end-feet wrap around cerebral blood vessels, contributing to the blood-brain barrier and participating in neurovascular coupling (dilating blood vessels in active brain regions through gliotransmitter release, generating the BOLD signal measured by fMRI). Astrocytes buffer extracellular K⁺ through Kir4.1 channels (spatial buffering — taking up K⁺ accumulating during neuronal firing and redistributing it), preventing the depolarising effect of elevated extracellular K⁺. They recycle glutamate released at synapses through high-affinity EAAT2/GLT-1 transporters, converting it to glutamine (via glutamine synthetase) for return to neurons (the glutamate-glutamine cycle). They can also release gliotransmitters (glutamate, ATP, D-serine) that modulate synaptic transmission, supporting the concept of the tripartite synapse: presynaptic terminal + postsynaptic density + surrounding astrocyte processes.
Oligodendrocytes and Schwann Cells — Myelination
These two cell types produce the myelin sheath that insulates axons, enabling saltatory conduction and dramatically increasing conduction velocity. In the CNS, oligodendrocytes each myelinate segments of up to 50 different axons simultaneously by extending flat membrane processes that wrap concentrically around the axon shaft. In the PNS, Schwann cells myelinate a single internode of a single axon — a key distinction that explains why peripheral nerve injuries regenerate (the Schwann cell tube guides regrowth) while CNS injuries generally do not (oligodendrocyte-derived myelin components, including Nogo, MAG, and OMgp, actively inhibit axonal regrowth). Myelin is composed of approximately 70% lipid (including galactocerebroside and sphingomyelin) and 30% protein (myelin basic protein, proteolipid protein, myelin-associated glycoprotein), with a water content of only 40% compared to ~80% for most cell membranes — its high lipid content is what makes it an effective electrical insulator.
Microglia — Neural Immune Sentinels
Microglia are the resident immune cells of the CNS — derived from yolk sac progenitors during embryonic development (not from the same lineage as astrocytes and oligodendrocytes), they represent approximately 10–15% of all CNS cells. In the healthy adult brain, microglia are in a surveilling “resting” state with ramified morphologies, constantly extending and retracting their fine processes to monitor the surrounding neural tissue for signs of pathology (damage-associated molecular patterns, dead cells, misfolded proteins, pathogens) while also participating in physiological synaptic pruning (removing underactive synapses through complement-mediated engulfment — a process critical for proper circuit refinement during development and potentially dysregulated in conditions like schizophrenia and Alzheimer’s disease). In response to injury, infection, or protein aggregation, microglia undergo transformation to an activated phenotype — retracting their processes, increasing in size, upregulating inflammatory mediators (cytokines, reactive oxygen species), and phagocytosing cellular debris and pathogens.
Resting Membrane Potential — the Electrochemical Baseline of Neural Signalling
Every aspect of neural signalling — action potential generation, synaptic current flow, receptor activation, and neurotransmitter release — is superimposed on a baseline electrical potential difference across the neuronal plasma membrane. This resting membrane potential (RMP) of approximately -70 mV (inside negative relative to outside) is not a static equilibrium but a dynamic steady state, maintained by the continuous operation of ion pumps against the constant dissipative flow of ions through leak channels. Understanding its origin requires understanding two physical forces acting simultaneously on each ion species: the concentration gradient (chemical driving force) and the electrical gradient (electrical driving force).
Intracellular vs extracellular ion concentrations (mammalian neuron): Ion Inside (mM) Outside (mM) Equilibrium potential (E) K⁺ 140 5 E_K = −90 mV (Nernst) Na⁺ 12 145 E_Na = +60 mV (Nernst) Cl⁻ 4 110 E_Cl = −89 mV (Nernst) Ca²⁺ 0.0001 2.5 E_Ca = +130 mV (Nernst) A⁻ (org) 385 ~0 Non-permeant (fixed negative charge) Nernst equation for equilibrium potential: E_ion = (RT / zF) × ln ([X]_out / [X]_in) At 37°C: E_ion = (61.5 mV / z) × log₁₀([X]_out / [X]_in) Goldman-Hodgkin-Katz (GHK) equation — resting potential with multiple ions: V_m = (RT/F) × ln( (P_K[K⁺]_o + P_Na[Na⁺]_o + P_Cl[Cl⁻]_i) / (P_K[K⁺]_i + P_Na[Na⁺]_i + P_Cl[Cl⁻]_o) ) At rest: P_K : P_Na : P_Cl ≈ 1 : 0.04 : 0.45 K⁺ dominates → V_m close to E_K but depolarised from it by Na⁺ leak Na⁺/K⁺-ATPase contribution: 3 Na⁺ extruded : 2 K⁺ imported per ATP hydrolysed Electrogenic: net outward current adds −3 to −5 mV to resting potential Primary role: MAINTAINING ion gradients, not generating the potential Consumes ~25% of total neuronal ATP under active signalling conditions
The resting membrane potential matters for neural signalling in three critical ways. First, it represents stored electrochemical potential energy that can be rapidly released when channels open during an action potential or synaptic current — the membrane is pre-loaded for fast signalling. Second, the exact value of the resting potential determines the distance from threshold that excitatory inputs must overcome to generate an action potential — small changes in resting potential (from, for example, persistent Na⁺ or K⁺ conductances, or sustained background synaptic input) shift the neuron’s excitability up or down. Third, deviations from the normal resting potential — such as those caused by hypoxia (ATP depletion impairing the Na⁺/K⁺-ATPase and causing depolarisation) or hyperkalemia (elevated extracellular K⁺ reducing the K⁺ concentration gradient and depolarising the membrane) — can cause pathological neural activity or, in extremis, permanent membrane depolarisation and neuronal death.
Action Potential — Generation, Phases, and Propagation
The action potential is the information-carrying electrical signal of the nervous system. It is a discrete, stereotyped, all-or-nothing event: below a certain membrane potential threshold (approximately -55 mV in most neurons), no action potential occurs; at or above threshold, a full-amplitude action potential of approximately 100 mV total swing (from -70 mV resting to +30–40 mV peak and back) is generated with a characteristic waveform that is essentially identical regardless of the magnitude of the triggering stimulus. Information is therefore encoded not in action potential amplitude but in action potential frequency (rate coding) and precise timing relative to other neurons (temporal coding).
Resting Potential
The pre-stimulus baseline. Na⁺ and K⁺ channels are mostly closed; the small K⁺ leak maintains the negative interior. No action potential is occurring.
Threshold
The critical voltage at which voltage-gated Na⁺ channel opening becomes self-sustaining (positive feedback — more depolarisation opens more channels). Below this: no AP. At or above: full AP.
Peak (Overshoot)
The membrane potential at the peak of the action potential, where inward Na⁺ current is maximum. The membrane briefly becomes positive inside — approaching (but not reaching) the Na⁺ equilibrium potential of +60 mV.
Repolarisation
Na⁺ channels inactivate (close via ball-and-chain mechanism) and delayed-rectifier K⁺ channels open, driving K⁺ outward. The membrane returns toward the resting potential within ~1 ms.
After-Hyperpolarisation
K⁺ channels close slowly, producing a brief undershoot below the resting potential. During this phase the neuron is harder (relatively refractory) to re-excite until channels close and the Na⁺/K⁺-ATPase restores gradients.
Refractory Periods
Absolute refractory (during Na⁺ channel inactivation — no AP possible regardless of stimulus). Relative refractory (during after-hyperpolarisation — AP possible with suprathreshold stimulus only). Limits maximum firing frequency to ~500–1000 Hz.
Alan Hodgkin and Andrew Huxley’s 1952 series of papers on the squid giant axon (which at ~1 mm diameter could be impaled with two electrodes for voltage-clamp recording) constitutes one of the most influential achievements in biophysics. By controlling membrane voltage precisely and measuring the resulting ionic currents, they separated the total membrane current into Na⁺ and K⁺ components and described the kinetics of each with mathematical equations involving three gating variables: m (Na⁺ activation), h (Na⁺ inactivation), and n (K⁺ activation). Their model predicted the full waveform of the action potential, conduction velocity, refractory periods, and the effects of temperature and pharmacological manipulation — and did so from first principles of physical chemistry. They were awarded the Nobel Prize in Physiology or Medicine in 1963 (shared with John Eccles). The Hodgkin-Huxley formalism remains the foundation of all computational neuroscience and membrane physiology to this day.
Channel pharmacology: Tetrodotoxin (TTX, from pufferfish) blocks voltage-gated Na⁺ channels from the outside (Na⁺ channel pore-blocking toxin — a critical tool in neurophysiology research and a deadly marine toxin). Tetraethylammonium (TEA) blocks delayed-rectifier K⁺ channels. Local anaesthetics (lidocaine, bupivacaine) block Na⁺ channels from the intracellular side, inhibiting action potential generation in peripheral sensory and motor fibres — the mechanism of regional anaesthesia.
Myelination and Saltatory Conduction — Speed, Efficiency, and the Nodes of Ranvier
The nodes of Ranvier are structurally complex specialised membrane domains formed by the cooperative interaction of the axon membrane, the myelinating cell (oligodendrocyte or Schwann cell), and the extracellular matrix. They are flanked by paranodal loops (where the myelin sheath is anchored to the axolemma through a junctional complex involving Caspr and contactin on the axon and NF155 on the glial side) and juxtaparanodal regions (where Kv1 K⁺ channels cluster). This precise nodal architecture ensures that the inward Na⁺ current at each node (through Nav1.6 channels at densities of approximately 1,000–2,000 channels/µm², compared to <25/µm² in internodal regions) is large enough to reliably depolarise the next node — the safety factor for saltatory conduction in peripheral nerves is approximately 5–7 times the minimum current needed for transmission, providing resilience against partial demyelination.
Synapse Structure — the Physical Site of Interneuronal Communication
The synapse is the point of functional contact between a presynaptic neuron and its target cell (postsynaptic neuron, muscle fibre, or gland cell). The term was coined by Charles Sherrington in 1897 from Greek roots meaning “to clasp together” — a prescient choice, as the synapse is precisely a site where two cells are held in close juxtaposition by specific adhesion molecules while maintaining a physical separation (the synaptic cleft) across which chemical messengers are passed. The human brain contains an estimated 100–500 trillion synapses, each one a site of modifiable information transfer, whose collective strength and pattern encodes all acquired knowledge, skills, and personality.
Electrical Synapses (Gap Junctions)
Formed by connexin proteins (connexons) that create direct cytoplasmic continuity between adjacent cells through 1.5–2 nm pores. Allow bidirectional current flow (no directionality restriction), are extremely fast (essentially no delay), and synchronise firing in electrically coupled neuron populations. Found in the inferior olive, retina, and inhibitory interneuron networks. Pannexin channels form one-way hemichannels. Gap junctions are dynamically regulated by Ca²⁺, pH, and phosphorylation — not static conductors. Cardiac action potential propagation and smooth muscle coordination rely on gap junction coupling.
Chemical Synapses — Unidirectional Signal Transduction
The predominant synapse type in the mammalian nervous system. The presynaptic terminal and postsynaptic density are separated by a ~20–40 nm cleft. Transmission is unidirectional (presynaptic → postsynaptic), amplifiable, modulatable, and introduces a synaptic delay of ~0.5–1 ms (the time for Ca²⁺ influx, vesicle fusion, NT diffusion, and receptor activation). Chemical synapses enable computation: the postsynaptic response is determined not only by presynaptic activity but also by the type of neurotransmitter, receptor expression, second messenger cascades, and neuromodulator status — allowing for a vastly richer range of responses than electrical synapses permit.
Postsynaptic Density (PSD)
The PSD is an electron-dense structure beneath the postsynaptic membrane, 30–60 nm thick and 250–500 nm in diameter, composed of hundreds of structural and signalling proteins including neurotransmitter receptors (AMPA, NMDA, mGluR, GABA-A), scaffolding proteins (PSD-95, Homer, Shank, Gephyrin), signalling enzymes (CaMKII, PI3K, Src kinase), and cytoskeletal anchors. PSD-95 organises excitatory synapses by anchoring NMDA receptors and linking them to downstream signalling complexes. The composition of the PSD changes during synaptic plasticity — AMPA receptor insertion (potentiation) or removal (depression) occurs in minutes, while structural changes in PSD protein content underlie hours-to-days long-term plasticity.
Synaptic Transmission — the Molecular Steps from Action Potential to Receptor Activation
Chemical synaptic transmission is a precisely choreographed sequence of molecular events that translates an electrical presynaptic signal into a chemical messenger signal and then back into an electrical postsynaptic response. The entire sequence — from action potential arrival to postsynaptic receptor activation — takes approximately 0.5 to 1 millisecond at a fast glutamatergic synapse, compared to the milliseconds-to-seconds timescale for most intracellular signalling cascades. This speed is achieved not by rapid diffusion chemistry per se but by the pre-positioning of all components (Ca²⁺ channels, docked vesicles, postsynaptic receptors, uptake transporters) in exact spatial registration before the action potential arrives.
Action Potential Arrives at the Terminal
The propagating action potential depolarises the presynaptic axon terminal membrane from its resting potential of approximately -70 mV to approximately +30 to +40 mV within ~0.5 ms. This rapid depolarisation is the trigger for all subsequent steps and distinguishes presynaptic activity from subthreshold depolarisations, which release little neurotransmitter.
Voltage-Gated Ca²⁺ Channels Open
Depolarisation activates P/Q-type (Cav2.1) and N-type (Cav2.2) voltage-gated Ca²⁺ channels concentrated in the presynaptic active zone directly above the docked vesicle pool. Ca²⁺ floods inward down its enormous concentration gradient ([Ca²⁺] outside ~2.5 mM; inside ~100 nM at rest — a 25,000-fold gradient). The resulting Ca²⁺ microdomain at the active zone reaches concentrations of approximately 100–200 µM within 50–100 nm of the channel mouth — far exceeding the bulk cytoplasmic Ca²⁺ concentration reached elsewhere in the terminal and explaining the exquisite spatial specificity of vesicle fusion.
Ca²⁺ Binds Synaptotagmin — the Fusion Trigger
Synaptotagmin-1 (the primary Ca²⁺ sensor for fast synchronous neurotransmitter release) is a vesicle membrane protein with two Ca²⁺-binding C2 domains (C2A and C2B) that bind 3–5 Ca²⁺ ions collectively with low affinity (Kd ~10–200 µM) — ensuring that the sensor only activates in the high-Ca²⁺ microdomain immediately adjacent to open Ca²⁺ channels. Upon Ca²⁺ binding, synaptotagmin-1 undergoes conformational changes that relieve its inhibitory clamping of the SNARE complex and insert its C2 domains into the inner leaflet of the presynaptic plasma membrane, dramatically accelerating membrane fusion.
SNARE Complex Drives Membrane Fusion
The SNARE (Soluble NSF Attachment Protein Receptor) complex mediates the actual membrane fusion event. It is formed by the coiled-coil assembly of three proteins: synaptobrevin-2/VAMP2 (on the vesicle membrane), and SNAP-25 and syntaxin-1A (on the target presynaptic membrane). The progressive zippering of the SNARE bundle from N-terminus to C-terminus pulls the vesicle membrane into intimate contact with the presynaptic plasma membrane, eventually driving the formation of a fusion pore through which neurotransmitter is released into the cleft. NSF (N-ethylmaleimide-sensitive factor) and α-SNAP disassemble used SNARE complexes after fusion for recycling. Clostridial neurotoxins (botulinum toxin, tetanus toxin) are zinc endoproteases that selectively cleave specific SNARE proteins — botulinum toxins cleave SNAP-25 or synaptobrevin, blocking ACh release at the NMJ and causing the flaccid paralysis of botulism.
Neurotransmitter Release and Diffusion
Vesicle contents — typically several thousand neurotransmitter molecules per vesicle for small-molecule neurotransmitters (a single vesicle of acetylcholine contains ~5,000–10,000 ACh molecules) — are released into the synaptic cleft by exocytosis. Neurotransmitter molecules diffuse across the ~20–40 nm cleft in approximately 0.01–0.1 ms, driven purely by concentration gradient. The concentration of transmitter in the cleft briefly peaks at hundreds of micromolar directly below the active zone, then declines rapidly due to diffusion, transporter uptake, and enzymatic degradation. The geometry of the cleft, the density of postsynaptic receptors, and the rate of clearance collectively determine how much postsynaptic receptor activation occurs.
Receptor Binding and Postsynaptic Response
Neurotransmitter binds to receptors in the postsynaptic density. Ionotropic receptors (ligand-gated ion channels such as AMPA, NMDA, GABA-A, glycine receptors, and nicotinic AChRs) open their intrinsic ion channels within less than 1 ms of NT binding, producing immediate changes in ion conductance and membrane potential. Metabotropic receptors (G-protein-coupled receptors such as metabotropic glutamate receptors, GABA-B, muscarinic AChRs, dopamine, serotonin, and adrenergic receptors) activate intracellular second-messenger cascades (cAMP, IP3/DAG, Ca²⁺ release) on a timescale of hundreds of milliseconds to seconds, producing modulatory effects on neuronal excitability, receptor sensitivity, and gene expression that outlast the initial neurotransmitter signal by many orders of magnitude.
Signal Termination — Reuptake, Degradation, and Diffusion
Rapid and precise termination of neurotransmitter action is as important as its initiation. Three mechanisms clear neurotransmitter from the cleft: (1) Reuptake transporters on presynaptic terminals and astrocytes actively transport transmitters back out of the cleft using the Na⁺ gradient as energy — glutamate (EAAT1–5), dopamine (DAT, target of cocaine and methylphenidate), serotonin (SERT, target of SSRIs and tricyclic antidepressants), and noradrenaline (NET). (2) Enzymatic degradation in the cleft — acetylcholinesterase (AChE) hydrolyses ACh in the NMJ and cholinergic CNS synapses at rates of ~14,000 molecules/second per enzyme molecule; monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) degrade monoamines intracellularly after reuptake. (3) Diffusion out of the cleft into the perisynaptic space, where lower receptor density and higher distance from release reduce the probability of receptor binding — spillover transmission to extrasynaptic or neighbouring synaptic receptors occurs at high-frequency stimulation or where clearance is slow.
Vesicle Recycling — Restoring Release Capacity
After exocytosis, the vesicle membrane must be retrieved from the presynaptic plasma membrane and recycled — either through clathrin-mediated endocytosis (the dominant pathway at low-frequency stimulation, taking ~30–60 seconds for the full cycle), kiss-and-run (partial fusion without full collapse, allowing rapid vesicle reuse at the fusion pore), or bulk endocytosis (membrane retrieval in large endosomal structures at high-frequency stimulation). Retrieved membrane is sorted in the endosomal system, refilled with neurotransmitter by vesicular transporters (VGLUTs for glutamate, VGAT for GABA, VAChT for ACh) using the H⁺ electrochemical gradient across the vesicle membrane, and returned to the readily releasable pool (typically 5–25 vesicles docked directly at active zones) or reserve pool (hundreds of vesicles tethered to the cytoskeleton) for future release cycles.
Neurotransmitters — Chemical Classes, Receptors, and Physiological Roles
Over 100 compounds qualify as neurotransmitters or neuromodulators in the vertebrate nervous system. They are conventionally divided by chemical structure and synthesis pathway into several major classes, each with distinct distributions, receptor families, and functional roles. The concept of Dale’s principle — that a neuron releases the same transmitter(s) at all its synapses — holds generally true for classical small-molecule transmitters, though co-release of multiple transmitters (typically a fast small-molecule transmitter plus one or more neuropeptides) is now recognised as common.
| Neurotransmitter | Class | Primary Receptors | Key Functions | Clinical Relevance |
|---|---|---|---|---|
| Glutamate | Amino acid (excitatory) | AMPA, NMDA, kainate (ionotropic); mGluR1–8 (metabotropic) | Principal excitatory NT throughout CNS; LTP, learning, memory, sensory processing | Excitotoxicity in stroke/TBI; NMDA hypofunction in schizophrenia; epilepsy |
| GABA | Amino acid (inhibitory) | GABA-A (Cl⁻ channel, ionotropic); GABA-B (GIRK/cAMP, metabotropic) | Principal inhibitory NT in brain; network stabilisation, anxiety modulation, sleep | Benzodiazepines/barbiturates enhance GABA-A; GABA deficit in epilepsy; anxiety disorders |
| Acetylcholine | Quaternary amine (cholinergic) | Nicotinic nAChR (Na⁺/K⁺, ionotropic); Muscarinic M1–M5 (GPCR) | NMJ motor transmission; autonomic ganglia; parasympathetic effectors; cortical arousal; memory (basal forebrain) | Myasthenia gravis; Alzheimer’s (basal forebrain degeneration); organophosphate poisoning; anaesthesia |
| Dopamine | Monoamine (catecholamine) | D1–D5 (all GPCR; D1/D5 stimulate cAMP; D2/D3/D4 inhibit cAMP) | Reward prediction, motivation (mesolimbic); motor control (nigrostriatal); working memory, cognition (mesocortical) | Parkinson’s (dopamine loss); schizophrenia (D2 hyperactivity); addiction; antipsychotics block D2 |
| Serotonin (5-HT) | Monoamine (indoleamine) | 5-HT1–7 (mostly GPCR); 5-HT3 (ionotropic — cation channel) | Mood, emotional regulation; sleep-wake; appetite; social behaviour; emesis (5-HT3) | Depression/anxiety (SSRI target SERT); migraine (5-HT1B/D agonists); antiemetics (5-HT3 antagonists) |
| Noradrenaline (NE) | Monoamine (catecholamine) | α1, α2 (GPCR); β1, β2, β3 (GPCR) | Arousal, attention (locus coeruleus); sympathetic effectors (cardiac, vascular, bronchial) | Depression (NE deficiency); ADHD (NE reuptake inhibition); hypertension (β-blockers); PTSD |
| Glycine | Amino acid (inhibitory) | Glycine receptor (Cl⁻ channel, ionotropic) | Principal inhibitory NT in spinal cord and brainstem; motor coordination; pain modulation | Hyperekplexia (startle disease — glycine receptor mutation); strychnine poisoning blocks receptor |
| Endorphins/Enkephalins | Neuropeptide (opioid) | µ, δ, κ opioid receptors (GPCR) | Endogenous pain modulation (analgesia); reward; stress response; respiratory control | Opioid pharmacology (morphine, fentanyl); addiction; naloxone reversal; pain management |
95% of all serotonin in the human body is synthesised and stored in the enteric nervous system of the gut — not the brain
Despite serotonin’s identification in neuroscience primarily through its role in mood regulation, the vast majority of the body’s serotonin is in enterochromaffin cells of the intestinal mucosa, where it regulates gut motility, secretion, and vagal afferent signalling. This distribution underlies the GI side effects of SSRIs (serotonin reuptake inhibitors), the use of 5-HT3 antagonists as antiemetics, and the emerging understanding of gut-brain communication in mood disorders — the “gut-brain axis” in which gut-derived signals including serotonin influence CNS function through the vagus nerve and endocrine channels.
EPSPs, IPSPs, and Synaptic Integration — How Neurons Sum Their Inputs
A single synapse rarely fires a postsynaptic neuron or silences it definitively. Real neurons integrate thousands of synaptic inputs arriving simultaneously from hundreds of different presynaptic neurons, each contributing a small graded potential change to the postsynaptic membrane. The postsynaptic neuron’s decision to fire (reaching threshold) or not depends on the algebraic summation of all excitatory and inhibitory inputs active at any given moment — a process called synaptic integration that is both the computational heart of neural processing and the target of almost all neuroactive drugs.
Excitatory Postsynaptic Potential (EPSP)
An EPSP is produced when a neurotransmitter (most commonly glutamate acting on AMPA receptors) opens cation channels that allow Na⁺ to flow inward (and K⁺ to flow outward at the reversal potential of approximately 0 mV). The resulting net inward current depolarises the postsynaptic membrane — shifting it from, say, -70 mV toward -60 mV. This depolarisation is subthreshold (does not itself reach the -55 mV threshold for an action potential) but moves the membrane potential closer to threshold, increasing the probability that subsequent or simultaneous EPSPs will cumulatively reach it. EPSPs produced by AMPA receptor activation are rapid (rise time ~0.5 ms, duration ~3–5 ms) and provide the fast millisecond-timescale excitation required for rapid information transfer. A large EPSP at a single strongly connected synapse (or the near-simultaneous arrival of EPSPs at many synapses) can trigger an action potential in the postsynaptic cell — this is the fundamental mechanism of neural information transmission.
Inhibitory Postsynaptic Potential (IPSP)
An IPSP is produced when GABA (acting on GABA-A receptors) or glycine (acting on glycine receptors) opens Cl⁻ channels. At a typical resting membrane potential of -70 mV, the Cl⁻ equilibrium potential is approximately -75 to -80 mV (slightly more negative than the resting potential), so Cl⁻ flows inward, hyperpolarising the membrane toward -75 mV. This moves the membrane farther from the action potential threshold (-55 mV), making firing less likely — classical hyperpolarising inhibition. However, in certain developmental stages (immature neurons) and certain neuron types (e.g., some dorsal horn neurons), intracellular Cl⁻ is higher (due to the immature expression pattern of the Cl⁻ cotransporter NKCC1 rather than the mature KCC2), so E_Cl is less negative than the resting potential, making GABA-A activation depolarising rather than hyperpolarising. Even where GABA causes a small depolarisation, it still often produces “shunting inhibition” — the increased Cl⁻ conductance reduces the input resistance of the membrane, so EPSPs produce smaller voltage changes even when the driving force for Cl⁻ is depolarising.
Temporal and Spatial Summation — the Neural Adding Machine
Because individual EPSPs and IPSPs decay over a few milliseconds, and because a single EPSP is typically only 0.5–2 mV in amplitude (far below the ~15 mV needed to reach threshold from rest), action potential generation requires that multiple inputs summate their effects. Two mechanisms of summation operate simultaneously in every integrating neuron:
Repeated Inputs Before the Potential Decays
If the same presynaptic neuron fires repeatedly in rapid succession, and the interval between action potentials is shorter than the decay time of the EPSP (typically ~5–10 ms for a single EPSP), successive EPSPs add together before each one has fully dissipated. A 5 Hz burst of presynaptic firing can therefore sum to a sustained depolarisation that pushes the postsynaptic cell toward threshold even if no single EPSP was sufficient alone. Temporal summation is enhanced at synapses with slow NMDA or metabotropic receptor components and reduced where fast AMPA-only EPSPs decay quickly and where the membrane time constant (τm = Rm × Cm) is short. High-frequency (tetanic) stimulation protocols used in LTP induction exploit temporal summation to produce the sustained postsynaptic depolarisation needed to unblock NMDA receptors.
Simultaneous Inputs from Different Synapses
If multiple different presynaptic neurons activate synapses on the same postsynaptic cell simultaneously, their individual EPSPs sum algebraically at the axon initial segment (where the summated potential is evaluated for threshold). Two synapses each producing 1 mV EPSPs simultaneously produce approximately 2 mV of total depolarisation. Spatial summation integrates information from many parallel inputs and is the mechanism by which neurons perform weighted voting across their entire presynaptic population — the postsynaptic cell fires when enough of its presynaptic partners are simultaneously active. The spatial distribution of synapses across the dendritic tree is not uniform: synapses closer to the soma have a larger effect at the axon hillock (less electrotonic decay along the dendritic shaft), while distal synapses require active dendritic amplification or temporal summation to contribute significantly.
Silencing Input Before It Starts
GABA can also reduce synaptic transmission presynaptically, through axo-axonic synapses where one neuron’s terminals contact another neuron’s axon terminals. Presynaptic GABA-A receptor activation on the contacting terminals causes Cl⁻ efflux (since presynaptic terminal Cl⁻ is higher than expected, making the equilibrium potential less negative), subtly depolarising the terminal and inactivating Na⁺ channels — reducing the amplitude of incoming action potentials and hence reducing Ca²⁺ entry and NT release. Alternatively, presynaptic GABA-B or opioid receptor activation reduces voltage-gated Ca²⁺ channel opening directly, reducing NT release probability. Presynaptic inhibition allows selective gating of specific sensory inputs without affecting the excitability of the postsynaptic neuron itself — the mechanism by which spinal dorsal horn interneurons gate pain signals in the gate control theory of pain.
Adjusting the Gain on Transmission
Neuromodulators (dopamine, serotonin, acetylcholine, noradrenaline, neuropeptides) act through metabotropic receptors and second-messenger cascades to alter neuronal excitability, synaptic strength, and plasticity over seconds to minutes — not generating fast EPSPs or IPSPs but changing the sensitivity of neurons to fast ionotropic inputs. Dopamine in prefrontal cortex modulates working memory by changing the gain on pyramidal neuron dendritic input integration. Acetylcholine in hippocampus and cortex enhances signal-to-noise ratio by suppressing recurrent connections and enhancing thalamocortical drive — the cellular mechanism of attentional modulation. Noradrenaline from the locus coeruleus shifts the input-output function of neurons throughout the brain in arousal and stress, prioritising alertness and focused attention over diffuse processing.
The Neuromuscular Junction — Neural Control of Skeletal Muscle
The neuromuscular junction is the specialised synapse between a motor neuron and a skeletal muscle fibre, and it is the prototypical chemical synapse in all of neuroscience — the site where most of the fundamental mechanisms of synaptic transmission were first characterised by Bernard Katz and colleagues in the 1950s–70s. The NMJ is distinguished from most CNS synapses by its enormous size (approximately 500–1,000 active zones per terminal vs. 1–10 per CNS bouton), its unique postsynaptic junctional fold architecture, and its near-100% reliability of transmission — every motor neuron action potential reliably produces a muscle fibre action potential and hence contraction, under normal physiological conditions.
Quantal Neurotransmitter Release — Katz’s Quantum Hypothesis
Bernard Katz and colleagues’ analysis of spontaneous miniature end-plate potentials (mEPPs) — tiny, randomly occurring depolarisations of approximately 0.5–1 mV recorded at the motor end plate in the absence of any nerve stimulus — revealed that acetylcholine is released not continuously but in discrete, fixed-size packets (quanta) corresponding to the contents of individual synaptic vesicles. This was the first direct evidence that neurotransmitter release is vesicular and quantal — not graded or continuous. An evoked end-plate potential (EPP) is simply the near-simultaneous release of many quanta (typically 100–400 quanta per action potential at a healthy NMJ), each producing an mEPP-sized unit response. The quantal content m = EPP amplitude / mEPP amplitude, and it follows Poisson statistics when release probability is low and binomial statistics more generally. The quantum hypothesis laid the theoretical foundation for the molecular understanding of vesicle exocytosis that followed over the next 60 years.
End-plate potential characteristics: the EPP depolarises the end-plate membrane by approximately 30–40 mV — large enough to well exceed the ~15 mV threshold for an action potential in the muscle fibre. This large safety factor (approximately 2–3 times threshold) means that partial block of NMJ transmission (by non-depolarising neuromuscular blockers such as rocuronium, vecuronium, or the snake venom α-bungarotoxin, which competitively block the nicotinic AChR) must reduce transmission to less than 30–50% of normal before failure of neuromuscular transmission and muscle weakness become apparent. AChE inhibitors (neostigmine, pyridostigmine) that prolong ACh in the cleft are used to reverse non-depolarising block and to treat myasthenia gravis, where autoantibodies reduce nAChR numbers and erode the safety factor, causing fatigable muscle weakness.
A motor unit is a single motor neuron plus all the muscle fibres it innervates through its axonal branches. Motor unit sizes vary from ~10 fibres in extraocular muscles (requiring fine, precise control) to ~1,000–2,000 fibres in large limb muscles (requiring powerful but less precise force production). The size principle of motor unit recruitment (Henneman’s size principle) states that during voluntary contraction, smaller motor units (innervating slow-twitch, fatigue-resistant type I fibres) are recruited first at low force levels, with progressively larger motor units (innervating fast-twitch type II fibres) recruited as force demand increases. This orderly recruitment, implemented through the input resistance differences between small and large motor neurons, optimises the matching of metabolic fibre properties to contraction duration and force requirements.
Graded force production from a single motor unit is achieved through rate coding — increasing the firing frequency of the motor neuron increases the summation of twitch contractions (incomplete tetanus → complete tetanus → tetanic fusion) until a smooth, sustained force plateau is reached. Voluntary force is therefore controlled by two independent mechanisms acting simultaneously: recruitment (how many motor units are active) and rate coding (how fast each active motor unit fires) — a two-dimensional control space that provides remarkable range and precision of force modulation.
Long-Term Potentiation and Synaptic Plasticity — the Cellular Logic of Learning
The brain’s ability to encode and store information — from the memory of a face to the acquisition of a motor skill — requires that neural circuits change their connectivity and synaptic weights in response to experience. The dominant cellular mechanism for this learning-related synaptic modification is long-term potentiation (LTP): an activity-dependent, long-lasting increase in the strength of synaptic transmission at specific synapses that have been repetitively activated. First described by Timothy Bliss and Terje Lømo in the rabbit hippocampus in 1973, LTP has since been demonstrated throughout the nervous system (neocortex, amygdala, cerebellum, striatum) but is best characterised at the CA3→CA1 Schaffer collateral synapses of the hippocampus — a region known to be critical for declarative memory formation in humans, as demonstrated by patient H.M.’s profound amnesia following bilateral hippocampal removal.
The coincidence detection property of the NMDA receptor — requiring simultaneous presynaptic activity and postsynaptic depolarisation — is the molecular implementation of Hebb’s synaptic learning rule: neurons that fire together, wire together. The NMDA receptor is the physical realisation of the associative learning postulate that Hebb proposed in 1949 on purely theoretical grounds.
Reflecting the convergence of Hebb’s 1949 learning rule with the molecular biology of NMDA receptor gating, a principle central to contemporary learning and memory neuroscience
Understanding LTP is not merely of academic interest — every pharmacological treatment for cognitive decline, every strategy to enhance learning, and every intervention targeting epilepsy, PTSD, or drug addiction ultimately intersects with the molecular mechanisms of synaptic plasticity at glutamatergic synapses.
Reflecting the therapeutic centrality of LTP mechanisms in neurological and psychiatric pharmacology, encompassing NMDA receptor modulators, AMPA receptor potentiators, and PDE inhibitors for cognitive enhancement
NMDA Receptor — the Coincidence Detector of Learning
The NMDA (N-methyl-D-aspartate) receptor is the molecular switch that enables LTP. Unlike AMPA receptors, which open upon glutamate binding alone, the NMDA receptor channel requires two simultaneous conditions to open: glutamate binding (ligand-gating, requiring glutamate plus the co-agonist glycine or D-serine) AND sufficient postsynaptic depolarisation to expel a Mg²⁺ ion that physically blocks the channel at resting potential (voltage-gating). At -70 mV resting potential, extracellular Mg²⁺ blocks the NMDA channel even when glutamate is bound. When the postsynaptic membrane is depolarised to approximately -40 mV or beyond (as occurs when simultaneous EPSPs summate), the Mg²⁺ block is relieved and the NMDA channel opens, allowing Ca²⁺, Na⁺, and K⁺ to flow through. This Ca²⁺ influx through NMDA receptors is the trigger for LTP induction.
The Ca²⁺ entering through NMDA receptors activates calcium/calmodulin-dependent protein kinase II (CaMKII) — an enzyme that phosphorylates AMPA receptors already in the synapse (increasing their single-channel conductance) and triggers trafficking of additional AMPA receptors from intracellular stores to the postsynaptic membrane (increasing synaptic AMPA receptor number). Both changes increase the amplitude of the EPSP for subsequent presynaptic activity — a larger depolarisation for the same amount of glutamate release — constituting the early phase of LTP (E-LTP, lasting 1–3 hours without further stimulation). Late-phase LTP (L-LTP, lasting hours to days and beyond) requires gene transcription and new protein synthesis, including BDNF (brain-derived neurotrophic factor), Arc, Homer, and structural components for dendritic spine enlargement and new spine formation — the morphological changes that physically increase the number of AMPA receptors a synapse can accommodate. For additional detail on synaptic plasticity mechanisms and their relationship to memory consolidation, see the NCBI Bookshelf neuroscience reference on synaptic plasticity and memory.
Autonomic Neurotransmission — Sympathetic vs Parasympathetic at the Effector Organ
The autonomic nervous system governs the physiological baseline and stress responses of all visceral organs — continuously adjusting heart rate, vascular tone, respiratory airway calibre, GI motility, glandular secretion, and metabolic activity to meet moment-to-moment homeostatic demands. Its two divisions — sympathetic and parasympathetic — typically exert opposing effects on shared target organs, enabling precise graded control by shifting the balance of dual innervation rather than turning one system completely on and the other completely off.
Sympathetic vs parasympathetic relative dominance at major target organs (indicative)
The chemical specificity of autonomic neurotransmission — different receptors for noradrenaline (adrenoreceptors) and acetylcholine (muscarinic and nicotinic receptors) in different tissues — creates a pharmacological landscape of exceptional therapeutic utility. β1-adrenoreceptor antagonists (metoprolol, atenolol — “cardioselective” beta-blockers) slow the heart without affecting bronchial β2 receptors at therapeutic doses, treating hypertension, angina, and arrhythmias. β2-agonists (salbutamol/albuterol — bronchodilators) relax airway smooth muscle in asthma and COPD without affecting cardiac rate significantly. Muscarinic M3 antagonists (ipratropium, tiotropium) block parasympathetic bronchoconstriction in COPD. Muscarinic antagonists (atropine) block the parasympathetic cardiac slowing effect of vagal overactivation and are used in bradycardia and organophosphate poisoning. α1-antagonists (tamsulosin, prazosin) relax smooth muscle in the bladder neck and prostate (benign prostatic hyperplasia treatment) and peripheral vasculature (hypertension).
The therapeutic breadth of autonomic drugs reflects the fact that virtually every organ in the body is under dual autonomic innervation — any drug targeting autonomic receptors has multi-organ effects that can be exploited therapeutically or represent adverse effects to manage. Selectivity for receptor subtypes (β1 vs β2, M2 vs M3, α1 vs α2) has been the major pharmacological strategy for improving the therapeutic index of autonomic drugs over the past 50 years.
Clinical Correlates — When Neural Signalling Fails
Neurological and psychiatric disorders are, at their molecular core, disorders of neural signalling. Ion channel mutations, neurotransmitter deficits or excesses, receptor autoantibodies, myelin destruction, neurotoxin exposure, ischaemic ATP depletion — all converge on the fundamental mechanisms of neural communication described in this guide. Understanding these mechanisms directly predicts and explains the clinical manifestations, and it rationalises the pharmacological, biological, and surgical interventions used in their treatment. The global burden of neurological disorders is enormous — approximately 1 in 6 people worldwide are affected by some form of neurological or mental health condition, making neurological disorders collectively the leading cause of disability-adjusted life years (DALYs) globally.
Multiple Sclerosis
Autoimmune demyelination of CNS axons by T-cell-mediated attack on myelin. Destroys saltatory conduction, slowing or blocking neural transmission. Relapsing-remitting course reflects incomplete remyelination by oligodendrocyte precursors during recovery. MRI white matter plaques diagnostic. Disease-modifying therapies target immune activation.
Parkinson’s Disease
Progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta → striatal dopamine depletion → basal ganglia circuit imbalance (excess indirect pathway inhibition) → bradykinesia, rigidity, resting tremor. Lewy body α-synuclein inclusions are the pathological hallmark. L-DOPA remains the most effective symptomatic treatment.
Epilepsy
Recurrent seizures from abnormal synchronised neuronal discharge — excessive excitation (glutamate, Na⁺ channel gain-of-function) or insufficient inhibition (GABA deficit, Cl⁻ channel loss-of-function). Antiepileptics target Na⁺ channels (carbamazepine, lamotrigine), GABA-A receptors (benzodiazepines, barbiturates), or Ca²⁺ channels (ethosuximide). Genetic channelopathies (SCN1A — Dravet syndrome) are increasingly identified.
Myasthenia Gravis
Autoantibodies against nicotinic AChRs (or MuSK) at the NMJ reduce functional receptor numbers, eroding the safety factor for neuromuscular transmission. Results in fatigable muscle weakness — worse with activity, better with rest. Anti-AChE drugs (pyridostigmine) increase synaptic ACh to partially compensate. Immunosuppression and plasmapheresis address the underlying autoimmune process.
Cholinergic and Glutamatergic Signalling Loss
The most common cause of dementia, characterised pathologically by amyloid-beta (Aβ) plaques and neurofibrillary tau tangles. Neurodegeneration preferentially affects cholinergic neurons of the basal forebrain (nucleus basalis of Meynert, diagonal band), reducing cortical and hippocampal ACh levels and impairing attentional and memory circuits. Glutamatergic synaptic failure — progressive loss of synapses and AMPA receptor expression in hippocampal circuits — correlates most directly with cognitive decline. Approved pharmacological treatments include AChE inhibitors (donepezil, rivastigmine, galantamine — symptomatic) and memantine (low-affinity NMDA receptor blocker that reduces excitotoxic background noise). Anti-amyloid immunotherapy (lecanemab) represents the first disease-modifying class to receive approval.
Excitotoxicity and the Ischaemic Cascade
Cerebral ischaemia from arterial occlusion (ischaemic stroke, ~85%) or haemorrhage (haemorrhagic stroke, ~15%) deprives neurons of oxygen and glucose, rapidly depleting ATP. Na⁺/K⁺-ATPase failure causes membrane depolarisation and massive glutamate release. NMDA and AMPA receptors are overactivated — Ca²⁺ overload triggers protease and lipase activation, mitochondrial dysfunction, reactive oxygen species generation, and apoptotic/necrotic death in the ischaemic core within minutes. The surrounding penumbra — where blood flow is reduced but not absent — can be salvaged if reperfusion (via thrombolysis with tPA or mechanical thrombectomy) is achieved within 4.5 hours (tPA) or up to 24 hours (thrombectomy) of symptom onset. The glutamate excitotoxicity cascade explains both the urgency of reperfusion therapy and why neuroprotective drugs targeting NMDA receptors have largely failed clinically — the therapy window is too narrow and the cascade too quickly irreversible.
Monoamine Deficits and Synaptic Modulation
The monoamine deficiency hypothesis of depression — reduced serotonin, noradrenaline, and/or dopamine signalling — remains the basis of current first-line pharmacotherapy, though the actual pathophysiology is substantially more complex. SSRIs (selective serotonin reuptake inhibitors: fluoxetine, sertraline, escitalopram) block SERT, increasing synaptic serotonin availability; SNRIs (venlafaxine, duloxetine) block both SERT and NET. Ketamine (a rapid-acting antidepressant) blocks NMDA receptors, increasing BDNF synthesis and rapidly restoring hippocampal synaptic connectivity in circuits that atrophy in chronic depression — suggesting that structural synaptic plasticity changes, rather than acute monoamine levels, underlie persistent mood disorders. GABA-A positive allosteric modulators (brexanolone, a neurosteroid) treat postpartum depression by modulating tonic inhibitory conductance.
Central Sensitisation and Synaptic Plasticity in Pain
Persistent pain — neuropathic pain, fibromyalgia, chronic back pain — involves central sensitisation: an LTP-like strengthening of synapses in the dorsal horn of the spinal cord and supraspinal pain circuits that amplifies nociceptive signalling even in the absence of ongoing tissue damage. AMPA receptor upregulation, NMDA receptor activation, reduced GABAergic and glycinergic inhibition (disinhibition), and microglia-mediated inflammatory signalling all contribute. NSAIDs target peripheral COX-mediated prostaglandin synthesis; gabapentinoids (gabapentin, pregabalin) reduce Ca²⁺ channel-mediated presynaptic NT release in the dorsal horn; opioids activate µ-opioid receptors to reduce both presynaptic NT release and postsynaptic excitability; ketamine blocks central NMDA-mediated sensitisation. Targeting the molecular mechanisms of synaptic plasticity in pain circuits is the major frontier in analgesic drug development.
Neuroscience and Physiology Writing Support — Every Academic Level
From first-year neurophysiology problem sets and A-Level synaptic transmission essays to postgraduate dissertations on synaptic plasticity or clinical neurology case studies — specialist writers cover all neural system topics with the conceptual depth and biological accuracy required for top marks.
Frequently Asked Questions About the Nervous System, Neurons, and Synaptic Transmission
Continue your studies: biology assignments · anatomy & physiology · science writing · lab reports · biology research papers · literature reviews · psychology writing · nursing science · dissertations · research papers · complex scientific assignments · biostatistics · data analysis · citation and referencing · proofreading & editing · public health · mental health nursing